PL2872487T3 - Sposób wytwarzania związków izochinolinowych - Google Patents
Sposób wytwarzania związków izochinolinowychInfo
- Publication number
- PL2872487T3 PL2872487T3 PL13740184T PL13740184T PL2872487T3 PL 2872487 T3 PL2872487 T3 PL 2872487T3 PL 13740184 T PL13740184 T PL 13740184T PL 13740184 T PL13740184 T PL 13740184T PL 2872487 T3 PL2872487 T3 PL 2872487T3
- Authority
- PL
- Poland
- Prior art keywords
- isoquinoline compounds
- making
- making isoquinoline
- compounds
- isoquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672191P | 2012-07-16 | 2012-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2872487T3 true PL2872487T3 (pl) | 2017-09-29 |
Family
ID=48857024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13740184T PL2872487T3 (pl) | 2012-07-16 | 2013-07-15 | Sposób wytwarzania związków izochinolinowych |
Country Status (21)
Country | Link |
---|---|
US (2) | US9340511B2 (pl) |
EP (2) | EP2872487B1 (pl) |
JP (1) | JP6196671B2 (pl) |
KR (1) | KR102145272B1 (pl) |
CN (2) | CN106083719B (pl) |
AU (1) | AU2013290437B2 (pl) |
BR (1) | BR112015001106B1 (pl) |
CA (1) | CA2879238C (pl) |
DK (1) | DK2872487T3 (pl) |
ES (1) | ES2631655T3 (pl) |
HU (2) | HUE034409T2 (pl) |
IL (1) | IL236625B (pl) |
IN (1) | IN2015KN00265A (pl) |
MX (1) | MX350922B (pl) |
MY (1) | MY171483A (pl) |
NZ (1) | NZ704660A (pl) |
PL (1) | PL2872487T3 (pl) |
PT (1) | PT2872487T (pl) |
SG (1) | SG11201500234YA (pl) |
WO (1) | WO2014014834A1 (pl) |
ZA (1) | ZA201500664B (pl) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006527200A (ja) | 2003-06-06 | 2006-11-30 | ファイブロゲン インコーポレイティッド | 窒素含有ヘテロアリール化合物および内因性エリトロポエチンを増加させる際のそれらの使用方法 |
NZ592741A (en) | 2008-11-14 | 2013-03-28 | Fibrogen Inc | Thiochromene derivatives as hif hydroxylase inhibitors |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
HUE041458T2 (hu) * | 2012-07-16 | 2019-05-28 | Fibrogen Inc | Prolil-hidroxiláz inhibitor kristályos alakjai |
WO2014014834A1 (en) * | 2012-07-16 | 2014-01-23 | Fibrogen, Inc. | Process for making isoquinoline compounds |
LT3003284T (lt) | 2013-06-06 | 2020-04-27 | Fibrogen, Inc. | Hif hidroksilazės inhibitoriaus farmacinės kompozicijos |
CN103694172A (zh) * | 2013-12-26 | 2014-04-02 | 辽宁亿灵科创生物医药科技有限公司 | 含氮杂芳基化合物的衍生物 |
WO2016034108A1 (zh) | 2014-09-02 | 2016-03-10 | 广东东阳光药业有限公司 | 喹啉酮类化合物及其应用 |
WO2016045125A1 (en) * | 2014-09-28 | 2016-03-31 | Merck Sharp & Dohme Corp. | Inhibitors of hif prolyl hydroxylase |
CN104447547B (zh) * | 2014-11-10 | 2017-04-19 | 苏州康润医药有限公司 | 4‑氨基异喹啉‑8‑甲酸甲酯的合成方法 |
CN106146490B (zh) * | 2015-03-27 | 2018-10-23 | 沈阳三生制药有限责任公司 | 被芳氧基或杂芳氧基取代的5-羟基-1,7-萘啶化合物、其制备方法及其制药用途 |
CN104892509B (zh) * | 2015-06-04 | 2018-03-09 | 苏州明锐医药科技有限公司 | 诺得司他的制备方法 |
CN106187888A (zh) * | 2016-07-18 | 2016-12-07 | 江苏德源药业股份有限公司 | Fg‑4592单晶及其制备方法 |
CN106478503A (zh) * | 2016-09-29 | 2017-03-08 | 上海勋和医药科技有限公司 | Roxadustat中间体的制备方法 |
CZ2016627A3 (cs) | 2016-10-07 | 2018-04-18 | Zentiva, K.S. | Způsob přípravy (7-fenoxy-4-hydroxy-1-methylisochinolin-3-karbonyl)glycinu (roxadustatu) a jeho intermediátů založený na souběžném otevírání oxazolového kruhu, štěpení etheru a tvorbě iminu |
CN107954931B (zh) * | 2016-10-17 | 2021-06-22 | 上海医药集团青岛国风药业股份有限公司 | 一种诺得司他的制备方法 |
EP3573615A4 (en) * | 2017-01-28 | 2020-10-28 | Kingchem Life Science LLC | PROCESS FOR THE PREPARATION OF 5-PHENOXY-1 (3H) ISOBENZOFURANONE |
WO2019106621A1 (en) * | 2017-12-01 | 2019-06-06 | Dr. Reddy's Laboratories Limited | Process for the preparation of roxadustat and its intermediates |
CN109956870A (zh) * | 2017-12-14 | 2019-07-02 | 南京卡文迪许生物工程技术有限公司 | 一种罗沙司他的合成方法及其中间体化合物 |
CN110218184B (zh) * | 2018-03-01 | 2022-09-27 | 广东东阳光药业有限公司 | 诺德司他共晶及其制备方法 |
WO2019174631A1 (zh) * | 2018-03-16 | 2019-09-19 | 上海医药集团股份有限公司 | 一种诺得司他的制备方法 |
CN110526813B (zh) * | 2018-05-24 | 2022-06-28 | 杭州科巢生物科技有限公司 | 异喹啉化合物的制备方法及其中间体 |
CN110028431B (zh) | 2018-06-05 | 2021-01-08 | 沈阳化工大学 | 一种三氟乙基硫醚(亚砜)取代苯类化合物及其用途 |
AU2019375983A1 (en) | 2018-11-09 | 2021-06-10 | Vivace Therapeutics, Inc. | Bicyclic compounds |
CN109776415B (zh) * | 2019-03-07 | 2020-11-17 | 福建南方制药股份有限公司 | 一种Roxadustat中间体的制备方法 |
MX2021012638A (es) | 2019-04-16 | 2022-01-04 | Vivace Therapeutics Inc | Compuestos biciclicos. |
RU2709493C1 (ru) * | 2019-08-01 | 2019-12-18 | Марат Феликсович Фазылов | Способ получения роксадустата |
US20220340532A1 (en) * | 2019-08-07 | 2022-10-27 | Teva Pharmaceuticals International Gmbh | Processes for the preparation of roxadustat and intermediates thereof |
CN112441975B (zh) * | 2019-09-03 | 2023-10-31 | 西藏嘉信景天药业有限公司 | 一种罗沙司他重要中间体的制备方法 |
CN112679431B (zh) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | 一种制备异喹啉酮类化合物的方法 |
CN112679430B (zh) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | 一种制备异喹啉酮类化合物的方法 |
US20230112619A1 (en) * | 2019-10-18 | 2023-04-13 | Shanghai Desano Chemical Pharmaceutical Co., Ltd. | Method for preparing isoquinolinone compounds |
CN113444042A (zh) * | 2020-03-27 | 2021-09-28 | 南京海润医药有限公司 | 一种罗沙司他的制备方法 |
CN115867537A (zh) * | 2020-04-21 | 2023-03-28 | 迈兰实验室有限公司 | 改进的罗沙司他的制备方法 |
CN111533691A (zh) * | 2020-06-08 | 2020-08-14 | 重庆三圣实业股份有限公司 | 一种罗沙司他的制备方法 |
EP4169906A4 (en) | 2020-06-19 | 2023-09-27 | Jumpcan (Shanghai) Medical Technology Co., Ltd | PROCESS FOR SYNTHESIS OF ROXADUSTAT AND ITS INTERMEDIATE AND ASSOCIATED INTERMEDIATE |
CN112409258A (zh) * | 2020-11-20 | 2021-02-26 | 杭州科巢生物科技有限公司 | 一种罗沙司他的制备方法 |
CN114644589A (zh) * | 2020-12-17 | 2022-06-21 | 鲁南制药集团股份有限公司 | 一种化合物n-[(4-羟基--1-甲基-3-异喹啉基)羰基]-甘氨酸的制备方法 |
US20230101768A1 (en) * | 2021-08-13 | 2023-03-30 | The Board Of Regents Of The University Of Texas System | Method to treat manganese toxicity and manganese-induced parkinsonism in humans |
CN115124467A (zh) * | 2022-07-11 | 2022-09-30 | 天津力生制药股份有限公司 | 一种罗沙司他关键中间体的制备方法 |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036964A (en) | 1973-10-11 | 1977-07-19 | Beecham Group Limited | Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis |
US3989704A (en) | 1973-10-30 | 1976-11-02 | Sandoz, Inc. | 3-Substituted-4-aryl isoquinolines |
DE2818423A1 (de) | 1978-04-27 | 1979-11-08 | Hoechst Ag | Neue isochinolinderivate und verfahren zu ihrer herstellung |
DE3233424A1 (de) | 1982-09-09 | 1984-03-15 | Hoechst Ag, 6230 Frankfurt | Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
US4558006A (en) | 1983-02-04 | 1985-12-10 | Kirin-Amgen, Inc. | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin |
US4559403A (en) | 1983-05-19 | 1985-12-17 | Hoffmann-La Roche Inc. | Substituted isoquinolines |
US4584379A (en) | 1985-01-22 | 1986-04-22 | Merrell Dow Pharmaceuticals Inc. | Isoquinoline thromboxane synthetase inhibitors |
US4667016A (en) | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
US4822800A (en) | 1986-06-09 | 1989-04-18 | Ortho Pharmaceutical Corporation | Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties |
US4952588A (en) | 1987-11-27 | 1990-08-28 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinoline-and 1-aryl-3-isoquinoline-carboxamides |
US4966906A (en) | 1987-11-27 | 1990-10-30 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-isoquinolinecarboxamides |
ATE149486T1 (de) | 1993-11-02 | 1997-03-15 | Hoechst Ag | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel |
ES2101420T3 (es) | 1993-11-02 | 1997-07-01 | Hoechst Ag | Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos. |
NZ270267A (en) | 1993-12-30 | 1997-03-24 | Hoechst Ag | 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions |
AU4515696A (en) | 1994-12-12 | 1996-07-03 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
IL135495A (en) | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
DK0944619T3 (da) | 1996-11-27 | 2007-02-05 | Bristol Myers Squibb Pharma Co | Hidtil ukendte integrinreceptorantagonister |
DE19746287A1 (de) | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
FR2779963A1 (fr) | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer |
IT1302677B1 (it) | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
WO2000064877A1 (en) | 1999-04-26 | 2000-11-02 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
IT1320162B1 (it) | 2000-02-09 | 2003-11-18 | Rotta Research Lab | Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico. |
FI20002044A0 (fi) | 2000-09-15 | 2000-09-15 | Orion Yhtymae Oyj | Comt-entsyymiä estäviä naftaleenijohdannaisia |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
US6855510B2 (en) | 2001-03-20 | 2005-02-15 | Dana Farber Cancer Institute, Inc. | Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
WO2002074981A2 (en) | 2001-03-21 | 2002-09-26 | Isis Innovation Ltd. | Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
CA2450625A1 (en) | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Isoquinoline compounds having antiinfective activity |
AU2002312371A1 (en) | 2001-06-13 | 2002-12-23 | Roland W. Burli | Aryl-benzimidazole compounds having antiinfective activity |
US6762318B2 (en) | 2001-12-03 | 2004-07-13 | Novo Nordisk A/S | Glucagon antagonists |
US8318703B2 (en) | 2001-12-06 | 2012-11-27 | Fibrogen, Inc. | Methods for improving kidney function |
CN1602360A (zh) | 2001-12-06 | 2005-03-30 | 法布罗根股份有限公司 | 提高内源性红细胞生成素(epo)的方法 |
US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
GB0229581D0 (en) * | 2002-12-19 | 2003-01-22 | Cyclacel Ltd | Use |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
JP2006527200A (ja) | 2003-06-06 | 2006-11-30 | ファイブロゲン インコーポレイティッド | 窒素含有ヘテロアリール化合物および内因性エリトロポエチンを増加させる際のそれらの使用方法 |
US20060251638A1 (en) | 2003-06-06 | 2006-11-09 | Volkmar Guenzler-Pukall | Cytoprotection through the use of hif hydroxylase inhibitors |
CA2532064A1 (en) | 2003-07-15 | 2005-02-03 | Merck & Co., Inc. | Hydroxypyridine cgrp receptor antagonists |
WO2005011696A1 (en) | 2003-08-01 | 2005-02-10 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
US7544699B2 (en) | 2003-08-08 | 2009-06-09 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
EP1766047B1 (en) | 2004-05-28 | 2009-09-23 | Fibrogen, Inc. | Hif prolyl hydroxylase activity assay |
AP2007004047A0 (en) * | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
ATE513833T1 (de) | 2005-03-02 | 2011-07-15 | Fibrogen Inc | Thienopyridinverbindungen und verfahren zu ihrer verwendung |
JP5390184B2 (ja) | 2005-06-06 | 2014-01-15 | ファイブローゲン、インコーポレーテッド | 貧血の改良された治療方法 |
WO2006138511A2 (en) | 2005-06-15 | 2006-12-28 | Fibrogen, Inc. | Use of hif 1alfa modulators for treatment of cancer |
CA2629833C (en) | 2005-11-28 | 2015-10-27 | Commvault Systems, Inc. | Systems and methods for classifying and transferring information in a storage network |
RU2457204C2 (ru) | 2006-01-27 | 2012-07-27 | Файброджен, Инк. | Цианоизохинолиновые соединения (варианты), фармацевтическая композиция на их основе, способ ингибирования активности гидроксилазы гипоксия-индуцибельного фактора (hif) и способ лечения и/или профилактики состояния, связанного с hif, и/или состояния, связанного с эритропоэтином, и/или анемии |
AU2007218051A1 (en) | 2006-02-16 | 2007-08-30 | Fibrogen, Inc. | Compounds and methods for treatment of stroke |
AU2007234408B2 (en) | 2006-04-04 | 2011-05-19 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
US20070293575A1 (en) | 2006-06-15 | 2007-12-20 | Fibrogen, Inc. | Compounds and methods for treatment of cancer-related anemia |
US7713986B2 (en) | 2006-06-15 | 2010-05-11 | Fibrogen, Inc. | Compounds and methods for treatment of chemotherapy-induced anemia |
US8269008B2 (en) | 2007-12-03 | 2012-09-18 | Fibrogen, Inc. | Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditions |
US8952160B2 (en) | 2008-01-11 | 2015-02-10 | Fibrogen, Inc. | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
US8324405B2 (en) | 2008-02-05 | 2012-12-04 | Fibrogen, Inc. | Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors |
WO2010022240A1 (en) | 2008-08-20 | 2010-02-25 | Fibrogen, Inc. | Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
NZ592741A (en) | 2008-11-14 | 2013-03-28 | Fibrogen Inc | Thiochromene derivatives as hif hydroxylase inhibitors |
US20140171465A1 (en) | 2011-01-13 | 2014-06-19 | Fibrogen, Inc. | Methods For Increasing Reticulocyte Hemoglobin Content |
CN103608346B (zh) | 2011-02-02 | 2016-06-15 | 菲布罗根有限公司 | 作为缺氧诱导因子(hif)羟化酶抑制剂的萘啶衍生物 |
JP6099644B2 (ja) * | 2011-07-22 | 2017-03-22 | ベイジン ベータ ファーマシューティカルズ カンパニー, リミテッド | プロリルヒドロキシラーゼ阻害剤としての化合物の多形体、およびその使用 |
EP2834220B1 (en) | 2012-03-09 | 2016-11-09 | Fibrogen, Inc. | 4-hydroxy-isoquinoline compounds as hif hydroxylase inhibitors |
HUE041458T2 (hu) | 2012-07-16 | 2019-05-28 | Fibrogen Inc | Prolil-hidroxiláz inhibitor kristályos alakjai |
WO2014014834A1 (en) | 2012-07-16 | 2014-01-23 | Fibrogen, Inc. | Process for making isoquinoline compounds |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
KR102233081B1 (ko) | 2013-01-24 | 2021-03-29 | 피브로겐, 인크. | 〔[1-시아노-5-(4-클로로페녹시)-4-하이드록시-아이소퀴놀린-3-카보닐]-아미노〕-아세트산의 결정 형태 |
LT3003284T (lt) | 2013-06-06 | 2020-04-27 | Fibrogen, Inc. | Hif hidroksilazės inhibitoriaus farmacinės kompozicijos |
-
2013
- 2013-07-15 WO PCT/US2013/050538 patent/WO2014014834A1/en active Application Filing
- 2013-07-15 KR KR1020157003197A patent/KR102145272B1/ko active Protection Beyond IP Right Term
- 2013-07-15 CN CN201610421229.1A patent/CN106083719B/zh active Active
- 2013-07-15 BR BR112015001106-3A patent/BR112015001106B1/pt active IP Right Grant
- 2013-07-15 PT PT137401840T patent/PT2872487T/pt unknown
- 2013-07-15 NZ NZ704660A patent/NZ704660A/en unknown
- 2013-07-15 US US14/414,879 patent/US9340511B2/en active Active
- 2013-07-15 IN IN265KON2015 patent/IN2015KN00265A/en unknown
- 2013-07-15 DK DK13740184.0T patent/DK2872487T3/en active
- 2013-07-15 PL PL13740184T patent/PL2872487T3/pl unknown
- 2013-07-15 MX MX2015000505A patent/MX350922B/es active IP Right Grant
- 2013-07-15 AU AU2013290437A patent/AU2013290437B2/en active Active
- 2013-07-15 EP EP13740184.0A patent/EP2872487B1/en active Active
- 2013-07-15 SG SG11201500234YA patent/SG11201500234YA/en unknown
- 2013-07-15 HU HUE13740184A patent/HUE034409T2/en unknown
- 2013-07-15 JP JP2015523159A patent/JP6196671B2/ja active Active
- 2013-07-15 MY MYPI2015000128A patent/MY171483A/en unknown
- 2013-07-15 CN CN201310302822.0A patent/CN103435546B/zh active Active
- 2013-07-15 EP EP17155678.0A patent/EP3219706A1/en not_active Withdrawn
- 2013-07-15 ES ES13740184.0T patent/ES2631655T3/es active Active
- 2013-07-15 CA CA2879238A patent/CA2879238C/en active Active
-
2015
- 2015-01-11 IL IL236625A patent/IL236625B/en active IP Right Grant
- 2015-01-29 ZA ZA2015/00664A patent/ZA201500664B/en unknown
-
2016
- 2016-03-17 US US15/073,251 patent/US9708269B2/en active Active
-
2022
- 2022-06-16 HU HUS2200030C patent/HUS2200030I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201500664B (en) | Process for making isoquinoline compounds | |
EP2890672A4 (en) | NEW PROCESS | |
GB201216921D0 (en) | Process | |
HK1244272A1 (zh) | 製備噻吩並嘧啶化合物的方法 | |
GB201207997D0 (en) | Process | |
HK1208673A1 (en) | Process for making hydroxylated cyclopentylpyrimidine compounds | |
HK1208451A1 (en) | Process for making hydroxylated cyclopentylpyrimidine compounds | |
ZA201408399B (en) | Hydroformylation process | |
GB201214326D0 (en) | Process | |
GB201213360D0 (en) | Process | |
EP2852660A4 (en) | PROCESS | |
PT2914574T (pt) | Processo novo | |
EP2855433A4 (en) | PROCESS FOR THE PREPARATION OF DIHALOPYRIDINES | |
EP2819995A4 (en) | PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL | |
GB201219224D0 (en) | Process | |
GB201219960D0 (en) | Process | |
IL233433A (en) | A process for making affluent | |
GB201218078D0 (en) | Process | |
HUP1200614A2 (en) | Process for development catalayzer | |
GB201216653D0 (en) | Process | |
GB201220666D0 (en) | Process for preparing chemical compounds | |
GB201209932D0 (en) | Improved process | |
GB201220746D0 (en) | Process | |
GB201202098D0 (en) | New process | |
GB201220610D0 (en) | Process |